Valuation: CVRx, Inc.

Market Cap 73.26M 63.28M 59.54M 54.11M 102M 7.02B 103M 698M 274M 3.51B 275M 269M 11.69B P/E 2026 *
-1.37x
P/E 2027 * -1.44x
Enterprise Value 83.77M 72.35M 68.07M 61.87M 116M 8.03B 118M 798M 313M 4.01B 315M 308M 13.37B EV / Sales 2026 *
1.42x
EV / Sales 2027 * 1.76x
Free-Float
85.67%
Yield 2026 *
-
Yield 2027 * -
1 day-0.73%
1 week+5.19%
Current month-47.15%
1 month-42.66%
3 months-53.96%
6 months-43.61%
Current year-61.48%
1 week 2.5
Extreme 2.5
3.24
1 month 2.2
Extreme 2.2
6
Current year 2.2
Extreme 2.2
9.84
1 year 2.2
Extreme 2.2
11.3
3 years 2.2
Extreme 2.2
33.14
5 years 2.2
Extreme 2.2
33.14
10 years 2.2
Extreme 2.2
33.14
Manager TitleAgeSince
Chief Executive Officer 60 11/02/2024
Director of Finance/CFO 43 30/09/2020
Chief Operating Officer 57 10/08/2025
Director TitleAgeSince
Director/Board Member 61 30/09/2008
Director/Board Member 57 30/06/2020
Director/Board Member 52 30/06/2020
Date Insider Type Main position Quantity % Market Cap.
13/08/26 Buy

Chief Operating Officer

26,223 0.0988%
12/08/26 Sell

Chief Operating Officer

-1,309 0.0049%
27/02/26 Free

Chief Executive Officer

404,763 1.5443%
Change 5-day change 1-year change 3-year change Capi.($)
-0.18%+5.19%-60.19%-84.31% 73.26M
-0.17%+0.09%+27.90%+30.00% 12.89B
+0.38%+0.67%+17.60%+31.69% 6.88B
-0.07%+5.21%+55.19%+49.88% 6.83B
+0.97%-0.56% - - 5.48B
+4.40%+6.44%-24.48%+57.93% 4.5B
-0.91%-5.55%-27.07%-24.01% 3.89B
-1.77%-2.21%+42.85%-44.38% 2.04B
-0.93%-2.75%+56.90%-7.95% 1.68B
+6.38%+1.66%-29.85%+128.22% 1.54B
Average +0.76%+1.10%+6.54%+15.23% 4.58B
Weighted average by Cap. +0.57%+0.68%+19.20%+29.78%

Financials

2026 *2027 *
Net sales 58.85M 50.83M 47.83M 43.47M 81.76M 5.64B 82.95M 561M 220M 2.82B 221M 216M 9.39B 66.18M 57.16M 53.78M 48.88M 91.93M 6.34B 93.28M 631M 247M 3.17B 248M 243M 10.56B
Net income -53.45M -46.17M -43.44M -39.48M -74.25M -5.12B -75.34M -510M -200M -2.56B -201M -196M -8.53B -52.14M -45.03M -42.37M -38.51M -72.42M -5B -73.48M -497M -195M -2.5B -196M -191M -8.32B
Net Debt 10.5M 9.07M 8.54M 7.76M 14.59M 1.01B 14.8M 100M 39.24M 503M 39.43M 38.58M 1.68B 42.94M 37.09M 34.89M 31.71M 59.65M 4.11B 60.52M 409M 160M 2.06B 161M 158M 6.85B
Logo CVRx, Inc.
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
Employees
223
Date Price Change Volume
18/08/26 US$2.735 -0.55% 353,232
17/08/26 US$2.750 -10.71% 1,036,926
14/08/26 US$3.080 +4.76% 1,897,812
13/08/26 US$2.940 +7.69% 1,223,391
12/08/26 US$2.730 +5.00% 1,372,273
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
2.750USD
Average target price
4.583USD
Spread / Average Target
+66.67%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CVRX Stock